HIV & Aging
A resource listing of articles, reports, websites, and ongoing clinical trials related to HIV and aging.
2019 TAG Update
TAG’s work in 2019 demonstrated our leadership towards an end to HIV, hepatitis C, and tuberculosis through hard-hitting, science-based activism. Excerpts of the media coverage we received walk you through a remarkable year of TAG’s work.
Treatment Action Group Applauds Progress on Ending HIV in New York, Cautions Against Complacency
Treatment Action Group (TAG) applauds progress in New York towards ending HIV as an epidemic, with record decreases in estimated statewide and citywide HIV incidence in 2018. TAG states that accelerating impact at the community level will be critical to reach the Ending the Epidemic 2020 targets.
TAGline November 2019
Vote Your ConSCIENCE: Elevating Health Justice in the 2020 Elections. 2020 marks the eighth U.S. presidential election cycle since Treatment Action Group’s founding in 1992. A hallmark of our activism has been to prepare for each presidential and congressional election cycle strategically, to ensure that whoever is elected, and whoever controls the House and the Senate, is informed about the best scientifically grounded research and policy and research programs.
Clinical Trials for People with Suboptimal Immune Reconstitution Despite HIV Suppression
Some individuals who initiate antiretroviral therapy (ART) experience limited recovery of CD4 T cell numbers despite suppression of HIV viral load to undetectable levels. The most common risk factors for this type of discordant response to ART are low CD4 T cell count at the time of starting and older age.
TAG Welcomes HHS Lawsuit Against Gilead; Urges Dramatic Scale-Up of Low-Cost PrEP
Treatment Action Group (TAG) welcomes the U.S. Department of Health and Human Services (HHS) pursuit of a lawsuit against Gilead Sciences, Inc., the manufacturer of Truvada and Descovy, the only two FDA-approved pills for pre-exposure prophlyaxis (PrEP) to prevent HIV.
Story: American Gene Technologies HIV Gene Therapy
November 2019 Examples of media coverage: Gene Tech Company Claims to Have Found a Cure for HIV/AIDS – NewNowNext, November 8, 2019 Researchers believe they’ve found the cure for HIV/AIDS – Pink News, November 8, 2019 Research Lab Believes They Have HIV/AIDS Cure – Instinct Magazine,…
A Landscape Analysis of HIV Cure-Related Clinical Trials in 2018
In August 2018, the Bill & Melinda Gates Foundation contracted TAG to undertake a survey of investigators conducting studies included in our “Research Toward a Cure” clinical trials listing, in order to obtain more detailed information about the current landscape of HIV cure-related clinical research.
Eight HIV/AIDS Research, Policy, and Advocacy Organizations File an Amici Curiae Brief in Staley v. Gilead – Background and Next Steps
On October 25, 2019, eight HIV/AIDS research, policy, and advocacy organizations filed an amicus brief in the U.S. District Court, in San Francisco, CA, in support of the plaintiffs in Staley v. Gilead.
Ensuring Community Leadership as Part of the Federal Ending the HIV Epidemic (EHE): A Plan for America
The ACT NOW: END AIDS (ANEA) coalition is seeking proposals for a new small grants program that aims to significantly increase local and state community leadership as part of the new federal Ending the HIV Epidemic (EHE): A Plan for America initiative.